Success Stories: EB-1A Approved for Research Specialist in Illinois in the Field of Bioinformatics
On December 23rd, 2014, We Received Another EB1-A (Alien of Extraordinary Ability) Approval for a Research Specialist in the Field of Bioinformatics (Approval Notice)
Position at the Time of Case Filing: Research Specialist
Country of Origin: India
Service Center: Nebraska Service Center (NSC)
State of Residence at the Time of Filing: Illinois
Approval Notice Date: December 23rd, 2014
Processing Time: 9 Months, 17 Days (Including RFE Response Time)
In this case, the client that we had the opportunity to work with was a Research Specialist from India in the field of Bioinformatics. He conducts his research in the highly specialized areas of high performance biological computing and next-generation sequence data analysis. His work had resulted in 6 peer-reviewed scientific articles and numerous presentations at national and international conferences; at the time that his case was filed, his publications had been cited at least 492 times by independent and leading researchers from prestigious institutions and organizations around the world, indicating the major significance of his work. He had also served on the editorial board for 3 distinctive, internationally-circulated journals. His superior level of expertise was confirmed in the following quote from an independent recommender, “In better describing the evolution of genomes across a variety of animals, [client] pioneered more accurate methods of analyzing the human genome…In spreading his discoveries to an international audience, biomedical scientists everywhere have access to enhanced knowledge of chromosome function. They can now identify genes causing certain diseases and devise methods of preventing and treating these diseases.” It was our goal to prove that our client qualified for classification as an Alien of Extraordinary Ability given that he sought to remain in the United States to continue work in the area of Bioinformatics, and that his continued research would substantially and prospectively benefit the United States. With the proof and documentation that we provided, his case was approved in 9 months and 17 days.